WHO ICTRP trial
Artemisinin based Combination therapy Trial
PACTR201803003018369 · Pan African Clinical Trials Registry (PACTR) · Not Recruiting
Key facts
| Trial ID | PACTR201803003018369 |
|---|---|
| Public title | Artemisinin based Combination therapy Trial |
| Scientific title | A Randomized Trial of Dihydroartemisinin-piperaquine (Malacur®) versus Artemether-lumefantrine (Coartem®) for Treatment of uncomplicated Plasmodium falciparum Malaria in Mali |
| Primary sponsor | Laboratorios SALVAT, S.A., |
| Registry | Pan African Clinical Trials Registry (PACTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Not Applicable |
| Countries | Mali |
| Conditions | Malaria;Malaria |
| Interventions | Dihydroartemisinin-piperaquine (Malacur);Artemether-lumefantrine (AL) |
| Registration date | Jan 26, 2018 |
| Target size | 0 |
| Registry page | pactr.samrc.ac.za |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: